Morphew, now executive associate dean for research and innovation at the University of Iowa College of Education, will join Johns Hopkins on Aug. 1.
Merck & Co. has appointed Dean Y. Li, M.D., Ph.D. as Vice President, Head of Translational Medicine. Li most recently served as the H.A. & Edna Benning Professor of Medicine and Cardiology at the University of Utah, as the Vice-Dean of research at the University of Utah Health Science Center, and as the Chief Scientific Officer of University of Utah Health Care.
The University of Scranton’s 24th president, Rev. Scott R. Pilarz, S.J., ’H15 will return to Scranton to serve as the Jesuit University’s president again. Lawrence R. Lynch, chair of the University’s Board of Trustees, made the announcement to the University community today. Father Pilarz will succeed Kevin. P. Quinn, S.J., whose term as president ends in June at the close of the 2016-17 academic year.
Hofstra University President Stuart Rabinowitz announced the appointment of Dr. Benjamin Rifkin, professor of modern languages and literature at Ithaca College, as the new Dean of the Hofstra College of Liberal Arts & Sciences.
Thank you to those who participated in our February 3 CompStudy Technology and Life Sciences webinars: Executive Compensation & Team Composition: Attracting and Retaining the Best and Brightest to Your Team. Below you will find links to the presentation materials.
Linda Hall Library has appointed Jane Davis as Vice President for Access and Digital Services.
On January 11, 2017, more than 100 life sciences industry leaders outlined guiding principles and best practices to improve gender diversity throughout industry.
Denise Stephens, university librarian at the University of California, Santa Barbara (UCSB), has been appointed vice provost and university librarian at Washington University in St. Louis, effective July 1, according to Provost Holden Thorp. Stephens succeeds Jeffrey G. Trzeciak, who left the university last July.
The market for medical devices historically has been dominated by big-ticket “physician preference items” such as artificial joints, spinal implants, and cardiac pacemakers. Venture capital and private equity investors have been eager to fund new firms in this expanding and lucrative domain. Changes in physician payment and organization are reducing the demand for these cost-increasing innovations, however, and redirecting the flow of investment capital.